These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

346 related items for PubMed ID: 18182259

  • 1. Plasmid DNA loaded chitosan nanoparticles for nasal mucosal immunization against hepatitis B.
    Khatri K, Goyal AK, Gupta PN, Mishra N, Vyas SP.
    Int J Pharm; 2008 Apr 16; 354(1-2):235-41. PubMed ID: 18182259
    [Abstract] [Full Text] [Related]

  • 2. Strong systemic and mucosal immune responses to surface-modified PLGA microspheres containing recombinant hepatitis B antigen administered intranasally.
    Jaganathan KS, Vyas SP.
    Vaccine; 2006 May 08; 24(19):4201-11. PubMed ID: 16446012
    [Abstract] [Full Text] [Related]

  • 3. Mannosylated niosomes as adjuvant-carrier system for oral genetic immunization against hepatitis B.
    Jain S, Singh P, Mishra V, Vyas SP.
    Immunol Lett; 2005 Oct 15; 101(1):41-9. PubMed ID: 15869802
    [Abstract] [Full Text] [Related]

  • 4. Cationic transfersomes based topical genetic vaccine against hepatitis B.
    Mahor S, Rawat A, Dubey PK, Gupta PN, Khatri K, Goyal AK, Vyas SP.
    Int J Pharm; 2007 Aug 01; 340(1-2):13-9. PubMed ID: 17446015
    [Abstract] [Full Text] [Related]

  • 5. Immune response by nasal delivery of hepatitis B surface antigen and codelivery of a CpG ODN in alginate coated chitosan nanoparticles.
    Borges O, Cordeiro-da-Silva A, Tavares J, Santarém N, de Sousa A, Borchard G, Junginger HE.
    Eur J Pharm Biopharm; 2008 Jun 01; 69(2):405-16. PubMed ID: 18364251
    [Abstract] [Full Text] [Related]

  • 6. Surface modified liposomes for nasal delivery of DNA vaccine.
    Khatri K, Goyal AK, Gupta PN, Mishra N, Mehta A, Vyas SP.
    Vaccine; 2008 Apr 24; 26(18):2225-33. PubMed ID: 18396362
    [Abstract] [Full Text] [Related]

  • 7. Development and characterization of chitosan coated poly-(ɛ-caprolactone) nanoparticulate system for effective immunization against influenza.
    Gupta NK, Tomar P, Sharma V, Dixit VK.
    Vaccine; 2011 Nov 08; 29(48):9026-37. PubMed ID: 21939718
    [Abstract] [Full Text] [Related]

  • 8. Evaluation of ISCOM vaccines for mucosal immunization against hepatitis B.
    Pandey RS, Dixit VK.
    J Drug Target; 2010 May 08; 18(4):282-91. PubMed ID: 19958131
    [Abstract] [Full Text] [Related]

  • 9. Chitosan-based nanoparticles for improving immunization against hepatitis B infection.
    Prego C, Paolicelli P, Díaz B, Vicente S, Sánchez A, González-Fernández A, Alonso MJ.
    Vaccine; 2010 Mar 19; 28(14):2607-14. PubMed ID: 20096389
    [Abstract] [Full Text] [Related]

  • 10. Poly(propyleneimine) dendrimer and dendrosome mediated genetic immunization against hepatitis B.
    Dutta T, Garg M, Jain NK.
    Vaccine; 2008 Jun 25; 26(27-28):3389-94. PubMed ID: 18511160
    [Abstract] [Full Text] [Related]

  • 11. Engineering enhancement of the immune response to HBV DNA vaccine in mice by the use of LIGHT gene adjuvant.
    Zhang Y, Jiang W, Fan Y, Wen J, Hao W, Qian M.
    J Virol Methods; 2008 Nov 25; 153(2):142-8. PubMed ID: 18722475
    [Abstract] [Full Text] [Related]

  • 12. Novel chitosan derivative nanoparticles enhance the immunogenicity of a DNA vaccine encoding hepatitis B virus core antigen in mice.
    Jiang L, Qian F, He X, Wang F, Ren D, He Y, Li K, Sun S, Yin C.
    J Gene Med; 2007 Apr 25; 9(4):253-64. PubMed ID: 17397104
    [Abstract] [Full Text] [Related]

  • 13. Mono-N-carboxymethyl chitosan (MCC) and N-trimethyl chitosan (TMC) nanoparticles for non-invasive vaccine delivery.
    Sayin B, Somavarapu S, Li XW, Thanou M, Sesardic D, Alpar HO, Senel S.
    Int J Pharm; 2008 Nov 03; 363(1-2):139-48. PubMed ID: 18662762
    [Abstract] [Full Text] [Related]

  • 14. Intranasal immunization with chitosan/pCETP nanoparticles inhibits atherosclerosis in a rabbit model of atherosclerosis.
    Yuan X, Yang X, Cai D, Mao D, Wu J, Zong L, Liu J.
    Vaccine; 2008 Jul 04; 26(29-30):3727-34. PubMed ID: 18524427
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Nasal vaccination with N-trimethyl chitosan and PLGA based nanoparticles: nanoparticle characteristics determine quality and strength of the antibody response in mice against the encapsulated antigen.
    Slütter B, Bal S, Keijzer C, Mallants R, Hagenaars N, Que I, Kaijzel E, van Eden W, Augustijns P, Löwik C, Bouwstra J, Broere F, Jiskoot W.
    Vaccine; 2010 Aug 31; 28(38):6282-91. PubMed ID: 20638455
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Hepatitis B surface antigen nanoparticles coated with chitosan and trimethyl chitosan: Impact of formulation on physicochemical and immunological characteristics.
    Tafaghodi M, Saluja V, Kersten GF, Kraan H, Slütter B, Amorij JP, Jiskoot W.
    Vaccine; 2012 Aug 03; 30(36):5341-8. PubMed ID: 22749834
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Pharmaceutical and immunological evaluation of mucoadhesive nanoparticles based delivery system(s) administered intranasally.
    Mangal S, Pawar D, Garg NK, Jain AK, Vyas SP, Rao DS, Jaganathan KS.
    Vaccine; 2011 Jul 12; 29(31):4953-62. PubMed ID: 21575664
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.